Literature DB >> 15955984

A population-based study on the visual outcome in 10-year-old preterm and full-term children.

Eva K Larsson1, Agneta C Rydberg, Gerd E Holmström.   

Abstract

OBJECTIVES: To report the visual outcome in prematurely born and full-term children at the age of 10 years and to evaluate the effects of prematurity per se, retinopathy of prematurity (ROP), and cryotreatment on visual acuity.
METHODS: The study included 216 prematurely born children and 217 children born at term from the same geographical area and study period. Best-corrected distance and near visual acuities were assessed with linear letter logarithm of the minimum angle of resolution charts. Crowding was evaluated.
RESULTS: Prematurely born children had reduced distance and near visual acuities compared with full-term children, even when children who had retinopathy of prematurity and neurologic disorders were excluded (P<.001). Children who had been treated with cryotherapy had the highest risk of a reduced visual acuity. Two percent of the prematurely born children were visually impaired (<20/60).
CONCLUSIONS: Although we found an overall good visual outcome in the prematurely born cohort, the risk of reduced visual acuity was greater than in full-term children. Children who had been treated with cryotherapy had the highest risk, but prematurity per se was also associated with reduced visual acuity.

Entities:  

Mesh:

Year:  2005        PMID: 15955984     DOI: 10.1001/archopht.123.6.825

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  18 in total

1.  Contrast sensitivity in 10 year old preterm and full term children: a population based study.

Authors:  E Larsson; A Rydberg; G Holmström
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

2.  Visual configural processing in adults born at extremely low birth weight.

Authors:  Karen J Mathewson; Daphne Maurer; Catherine J Mondloch; Saroj Saigal; Ryan J Van Lieshout; Louis A Schmidt
Journal:  Dev Sci       Date:  2019-08-27

3.  Choroidal thickness in regressed retinopathy of prematurity.

Authors:  M F Anderson; B Ramasamy; D T Lythgoe; D Clark
Journal:  Eye (Lond)       Date:  2014-10-03       Impact factor: 3.775

4.  Diffusion tensor imaging-based assessment of white matter tracts and visual-motor outcomes in very preterm neonates.

Authors:  Julia Pavaine; Julia M Young; Benjamin R Morgan; Manohar Shroff; Charles Raybaud; Margot J Taylor
Journal:  Neuroradiology       Date:  2015-12-21       Impact factor: 2.804

5.  Delayed luminance and chromatic contrast sensitivity in infants with spontaneously regressed retinopathy of prematurity.

Authors:  Rain G Bosworth; Shira L Robbins; David B Granet; Karen R Dobkins
Journal:  Doc Ophthalmol       Date:  2013-06-07       Impact factor: 2.379

6.  A safety and feasibility study of the use of 670 nm red light in premature neonates.

Authors:  A L Kent; M Broom; V Parr; R W Essex; M E Abdel-Latif; J E Dahlstrom; K Valter; J Provis; R Natoli
Journal:  J Perinatol       Date:  2015-02-19       Impact factor: 2.521

7.  Visual and cerebral sequelae of very low birth weight in adolescents.

Authors:  K Hellgren; A Hellström; L Jacobson; O Flodmark; M Wadsby; L Martin
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-02-21       Impact factor: 5.747

Review 8.  IGF-1 in retinopathy of prematurity, a CNS neurovascular disease.

Authors:  Raffael Liegl; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Early Hum Dev       Date:  2016-09-17       Impact factor: 2.079

9.  Retinal structural changes in preterm children without retinopathy of prematurity.

Authors:  Diogo Maleita; Rita Serras-Pereira; Inês Passos; Maria Elisa-Luís; Marta Alves; Ana Luísa Papoila; Cristina Brito; João Paulo Cunha; Joana Tavares Ferreira
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-11-04       Impact factor: 3.117

10.  White-matter injury is associated with impaired gaze in premature infants.

Authors:  Hannah C Glass; Shinji Fujimoto; Camilla Ceppi-Cozzio; Agnes I Bartha; Daniel B Vigneron; A James Barkovich; David V Glidden; Donna M Ferriero; Steven P Miller
Journal:  Pediatr Neurol       Date:  2008-01       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.